| Identification | Back Directory | [Name]
Lixisenatide acetate | [CAS]
1997361-87-1 | [Synonyms]
Lixisenatide acetate (320367-13-3 free base)
Lixisenatide,inhibit,Glucagon Receptor,Lixisenatide acetate (320367 13 3 free base),Inhibitor,Lixisenatide acetate (320367133 free base),GCGR |
| Hazard Information | Back Directory | [Uses]
Lixisenatide acetate salt is a useful research chemical used to increase proliferation of pancreatic beta cells in transplate patients with a DYRK1 A inhibitor and a GLP1R agonist. | [References]
[1] CHRISTIAN THORKILDSEN. Glucagon-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice.[J]. Journal of Pharmacology and Experimental Therapeutics, 2003, 307 2: 490-496. DOI: 10.1124/jpet.103.051987
[2] D TEWS J E U Werner. Enhanced protection against cytokine- and fatty acid-induced apoptosis in pancreatic beta cells by combined treatment with glucagon-like peptide-1 receptor agonists and insulin analogues.[J]. Hormone and Metabolic Research, 2008, 40 3: 172-180. DOI: 10.1055/s-2008-1042426 |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310; |
| Website: |
https://www.weikeqi-biotech.com/ |
| Company Name: |
InvivoChem
|
| Tel: |
13549236410 |
| Website: |
https://www.invivochem.cn/ |
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|